2 recruiting. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Ligufalimab: new trials by email Literature Review of Ligufalimab trials Research Report on Ligufalimab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study Comparing Ivonescimab Alone or Ivonescimab in Combination With Ligufalimab Versus Pembrolizumab for the Treatment of SCCHN Ivonescimab 10 mg/kg, Ligufalimab, Pembrolizumab (KEYTRUDA ®) - Squamous Cell Carcinoma Head and Neck Cancer (HNSCC) | Phase 3 | Recruiting | Groupe Oncologie Radiotherapie Tete et Cou | 780 | 2026-05-05 | 2026-05-20 |
| Ligufalimab and Cadonilimab in Advanced Liver Cancers Ligufalimab, Cadonilimab - Advanced Hepatocellular Carcinoma, Refractory Hepatocellular Carcinoma | Phase 2 | Recruiting | University of Texas Southwestern Medical Center | 64 | 2025-02-18 | 2026-02-27 |
Biliary Tract Neoplasms (1) · Carcinoma, Hepatocellular (1) · Head and Neck Neoplasms (1) · Squamous Cell Carcinoma of Head and Neck (1)
Groupe Oncologie Radiotherapie Tete et Cou (1) · University of Texas Southwestern Medical Center (1)
France (1) · United States (1)
David Hsieh, MD (1)
2025 (1)